ArticleSexual medicine2025
Comparative analysis of sexual function and psychological health in infertile patients with different ovarian dysfunctions.
Article in Sexual medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research trends on platelet-rich plasma in improving ovarian dysfunction: A bibliometric and visualization analysis.Regenerative therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Premature ovarian insufficiency (POI) and polycystic ovary syndrome (PCOS) are common reproductive disorders that negatively affect women's sexual and psychological health. Aim: This study aims to compare sexual function and psychological well-being in women with POI, PCOS, and healthy controls. Methods: A total of 340 women were recruited: 68 with POI, 104 with PCOS, and 168 healthy controls. Participants completed standardized questionnaires assessing sexual function (Female Sexual Function Index, FSFI), anxiety (Generalized Anxiety Disorder-7 [GAD-7]), and depression (Patient Health Questionnaire-9 [PHQ-9]). Descriptive statistics, Chi-square tests, and multivariable logistic regression were used to analyze the data. Outcomes: The primary outcomes included sexual function, assessed via FSFI total and domain scores (desire, arousal, lubrication, orgasm, satisfaction, and pain), and psychological well-being, evaluated through GAD-7 and PHQ-9 scores. Results: Women with POI and PCOS exhibited significantly lower FSFI total scores compared to controls (POI: 26.00 ± 3.50, PCOS: 26.13 ± 4.50, controls: 27.37 ± 3.24; Clinical Implications: Women with POI and PCOS require a comprehensive approach to care, addressing both sexual and psychological health to improve clinical outcomes. Strengths and Limitations: Strengths include a relatively large sample size and a comprehensive assessment of sexual and psychological health. Limitations include the case-control design and lack of long-term follow-up. Conclusion: POI and PCOS are significantly associated with sexual dysfunction and psychological distress, underscoring the need for integrated healthcare strategies to improve overall well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.